The high prevalence of the BRCA1 3450del4 founder mutation observed in the ovarian cancer cases suggests that there might be a regional population effect in Bogota and consequently this mutation might not have the same prevalence in other regions of Colombia, though the overall number of mutations detected was too small to draw conclusions. Here, BRCA1 is linked to ovarian carcinoma.